The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Mrs Rekha Salwan
    Born in September 1971
    Individual (1 offspring)
    Person with significant control
    2025-04-14 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Salwan, Neeraj
    Pharmacist born in September 1971
    Individual (11 offsprings)
    Officer
    2003-02-27 ~ now
    OF - director → CIF 0
    Mr Neeraj Salwan
    Born in September 1971
    Individual (11 offsprings)
    Person with significant control
    2016-06-01 ~ now
    PE - Has significant influence or controlCIF 0
  • 3
    Aggarwal, Narinder Kumar
    Accountant born in October 1956
    Individual (7 offsprings)
    Officer
    2011-02-24 ~ now
    OF - director → CIF 0
    Aggarwal, Narinder Kumar
    Individual (7 offsprings)
    Officer
    2011-02-24 ~ now
    OF - secretary → CIF 0
Ceased 3
parent relation
Company in focus

SALWAN PHARMACY LIMITED

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Intangible Assets
195,276 GBP2023-05-31
269,095 GBP2022-05-31
Property, Plant & Equipment
94,539 GBP2023-05-31
103,250 GBP2022-05-31
Fixed Assets - Investments
168,681 GBP2023-05-31
267,663 GBP2022-05-31
Fixed Assets
458,496 GBP2023-05-31
640,008 GBP2022-05-31
Total Inventories
82,034 GBP2023-05-31
109,218 GBP2022-05-31
Debtors
2,235,138 GBP2023-05-31
1,576,410 GBP2022-05-31
Cash at bank and in hand
370,839 GBP2023-05-31
831,541 GBP2022-05-31
Current Assets
2,688,011 GBP2023-05-31
2,517,169 GBP2022-05-31
Creditors
Current
1,238,513 GBP2023-05-31
1,324,970 GBP2022-05-31
Net Current Assets/Liabilities
1,449,498 GBP2023-05-31
1,192,199 GBP2022-05-31
Total Assets Less Current Liabilities
1,907,994 GBP2023-05-31
1,832,207 GBP2022-05-31
Creditors
Non-current
752,338 GBP2023-05-31
820,488 GBP2022-05-31
Net Assets/Liabilities
1,155,656 GBP2023-05-31
1,011,719 GBP2022-05-31
Equity
Called up share capital
3 GBP2023-05-31
3 GBP2022-05-31
Share premium
479,001 GBP2023-05-31
479,001 GBP2022-05-31
Capital redemption reserve
1 GBP2023-05-31
1 GBP2022-05-31
Retained earnings (accumulated losses)
676,651 GBP2023-05-31
532,714 GBP2022-05-31
Equity
1,155,656 GBP2023-05-31
1,011,719 GBP2022-05-31
Average Number of Employees
372022-06-01 ~ 2023-05-31
332021-06-01 ~ 2022-05-31
Intangible Assets - Gross Cost
Net goodwill
1,252,190 GBP2022-05-31
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
1,056,914 GBP2023-05-31
983,095 GBP2022-05-31
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
73,819 GBP2022-06-01 ~ 2023-05-31
Intangible Assets
Net goodwill
195,276 GBP2023-05-31
269,095 GBP2022-05-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
343,353 GBP2023-05-31
321,804 GBP2022-05-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
248,814 GBP2023-05-31
218,554 GBP2022-05-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
30,260 GBP2022-06-01 ~ 2023-05-31
Property, Plant & Equipment
Plant and equipment
94,539 GBP2023-05-31
103,250 GBP2022-05-31
Other Investments Other Than Loans
Cost valuation
168,681 GBP2023-05-31
267,663 GBP2022-05-31
Disposals
-100,000 GBP2023-05-31
Other Investments Other Than Loans
168,681 GBP2023-05-31
267,663 GBP2022-05-31
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
266,425 GBP2023-05-31
279,150 GBP2022-05-31
Other Debtors
Current, Amounts falling due within one year
232,591 GBP2023-05-31
80,466 GBP2022-05-31
Debtors
Current, Amounts falling due within one year
2,235,138 GBP2023-05-31
1,576,410 GBP2022-05-31
Bank Borrowings/Overdrafts
Current
94,726 GBP2023-05-31
121,302 GBP2022-05-31
Trade Creditors/Trade Payables
Current
679,753 GBP2023-05-31
711,072 GBP2022-05-31
Other Taxation & Social Security Payable
Current
235,864 GBP2023-05-31
179,089 GBP2022-05-31
Other Creditors
Current
226,069 GBP2023-05-31
311,406 GBP2022-05-31
Bank Borrowings/Overdrafts
Non-current
752,338 GBP2023-05-31
820,488 GBP2022-05-31
Bank Borrowings
Secured
847,064 GBP2023-05-31
941,790 GBP2022-05-31

Related profiles found in government register
  • SALWAN PHARMACY LIMITED
    Info
    Registered number SC244685
    4 Lynedoch Place, Glasgow G3 6AB
    Private Limited Company incorporated on 2003-02-27 (22 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2024-05-09
    CIF 0
  • SALWAN PHARMACY LTD
    S
    Registered number missing
    4, Lynedoch Place, Glasgow, Scotland, G3 6AB
    Limited Company
    CIF 1
  • SALWAN PHARMACY LTD
    S
    Registered number missing
    G3 6ab, 4, Lynedoch Place, Glasgow, United Kingdom, G3 6AB
    Limited Company
    CIF 2
  • SALWAN PHARMACY LTD
    S
    Registered number Sc 244685
    4, Lynedoch Place, Glasgow, Scotland, G3 6AB
    Company in Edinburgh, Scotland
    CIF 3
child relation
Offspring entities and appointments
Active 3
  • 1
    LEDGE 663 LIMITED - 2002-09-17
    4 Lynedoch Place, Glasgow
    Dissolved corporate (3 parents, 1 offspring)
    Equity (Company account)
    Retained earnings (accumulated losses)
    -251 GBP2020-05-31
    Person with significant control
    2016-04-06 ~ dissolved
    CIF 3 - Ownership of shares – 75% or moreOE
  • 2
    Reach Pharmacy, 4 Lynedoch Place, Glasgow
    Dissolved corporate (3 parents)
    Equity (Company account)
    Retained earnings (accumulated losses)
    -100 GBP2020-05-31
    Person with significant control
    2016-04-06 ~ dissolved
    CIF 1 - Ownership of shares – 75% or moreOE
  • 3
    4 Lynedoch Place, Glasgow, United Kingdom
    Dissolved corporate (3 parents)
    Equity (Company account)
    10 GBP2017-12-31
    Person with significant control
    2016-12-13 ~ dissolved
    CIF 2 - Ownership of shares – 75% or moreOE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.